Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs

International Journal of Clinical Practice, Supplement

Volumn , Issue 135, 2003, Pages 43-49

  Henry, David ^a   McGettigan, Patricia ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; DATA BASE; DRUG MEGADOSE; DUODENUM DISEASE; ESOPHAGUS INJURY; GASTROINTESTINAL TOXICITY; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STOMACH HEMORRHAGE; STOMACH PERFORATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; CONTROLLED CLINICAL TRIALS; GASTROINTESTINAL DISEASES; HUMANS; RISK FACTORS;

EID: 0037393479     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1992; 115: 787-796.
2. Bollini P, Garcia Rodriguez LA, Perez-Gutthann S et al. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 1992;152:1289-1292.
3. Henry D, Lim L, Garcia Rodriguez LA et al. Variability in risk of major upper gastrointestinal complications with individual NSAIDs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563-1566.